Health ❯ Healthcare ❯ Clinical Trials ❯ Phase 3 Trials

Efficacy Studies

India Tightens Oversight of GLP-1 Drugs as Semaglutide Generics Proliferate

Audits target a fast-growing market for low-cost semaglutide that opened when India’s patent lapsed.

FDA Clears 7.2‑mg Wegovy as India Enters Generic Semaglutide Era

Lilly’s Oral GLP-1 Orforglipron Tops Oral Semaglutide in Lancet Phase 3 Diabetes Trial

Pfizer’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

FDA Approves Darzalex Faspro as First Therapy for High-Risk Smoldering Multiple Myeloma

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk